TDOC - CIK 0001477449
Teladoc Health, Inc. trades as TDOC and has a market capitalization of $1.27 B, making it the #2457 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $2.53B, down 1.5% from the prior year and net income of -$200.32M. This page tracks Teladoc Health, Inc. through 1,535 SEC filings, with financial statements and metrics updated as new reports are filed.
Over the last 9 fiscal years Teladoc Health, Inc.'s revenue grew from $123.16M to $2.53B, a compound annual growth rate of 39.9%. Net profit margin expanded from -60.3% to -7.9% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| SD | - | 2026-05-26 |
| Insider trade | 4 | 2026-05-21 |
| Insider trade | 4 | 2026-05-21 |
| Insider trade | 4 | 2026-05-21 |
| Major company event | 8-K | 2026-05-21 |
| Insider trade | 4 | 2026-05-21 |
| Insider trade | 4 | 2026-05-21 |
| Insider trade | 4 | 2026-05-21 |
The largest companies sharing Teladoc Health, Inc.'s SEC industry classification (services-offices & clinics of doctors of medicine).
Teladoc Health, Inc. (TDOC) has a market capitalization of $1.27 B as of 2026-06-11, ranking #2457 among US-listed companies.
Teladoc Health, Inc. reported revenue of $2.53B for fiscal year 2025, a decrease of 1.5% year over year.
In its latest fiscal year Teladoc Health, Inc. reported a net loss of $200.32M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.